There are concerns about the quality of medical care. Examples of substandard care have been found in several diseases, yet the tools to measure the quality of palliative cancer services are limited. The goal of this project is to develop a core set of valid claims-based indicators of the quality of care delivered to patients with advanced malignancies. Such indicators could provide continuous quality monitoring, and allow rapid feedback to providers so that poor quality processes of care can be identified and improved. Candidate indicators will be identified through literature review and focus groups. The feasibility of using administrative data to monitor each indicator will be assessed using SEER-Medicare linked data and local institutional data. The SEER-Medicare dataset will then be used to select measures with sufficient variability amongst Health Care Service Areas to be useful as indicators, and where possible, empiric performance benchmarks will be determined. We will determine reliability and content validity by reviewing the charts of patients in the local dataset to see if the measures obtained from billing data are accurate. Construct validity will be assessed by looking for convergent validity among the indicators. In an already ongoing study, the family members of patients who have died from cancer are being asked about the quality of care the patient received. Criterion validity will be sought by correlating the performance of each indicator as applied to these patients' billing records, with the quality perceived by their family members. Based on the results of these validation exercises, we will determine a core indicator set, and then apply them to examine the correlations of provider or patient characteristics, such as race, sociodemographics, and academic affiliation, with quality of care. This project is important because it will, for the first time, provide valid means with which to assess the quality of medical services delivered to patients with advanced cancer, and will characterize variations in quality across different types of providers. Payers and patients will benefit from these results when selecting providers, and institutions and networks will be able to use them to monitor performance.
| Wright, Alexi A; Keating, Nancy L; Ayanian, John Z et al. (2016) Family Perspectives on Aggressive Cancer Care Near the End of Life. JAMA 315:284-92 |
| Cheung, Matthew C; Earle, Craig C; Rangrej, Jagadish et al. (2015) Impact of aggressive management and palliative care on cancer costs in the final month of life. Cancer 121:3307-15 |
| Saito, Akiko M; Landrum, Mary Beth; Neville, Bridget A et al. (2011) Hospice care and survival among elderly patients with lung cancer. J Palliat Med 14:929-39 |
| Ho, Thi H; Barbera, Lisa; Saskin, Refik et al. (2011) Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol 29:1587-91 |
| Datta, G Dabral; Neville, B A; Kawachi, I et al. (2009) Marital status and survival following bladder cancer. J Epidemiol Community Health 63:807-13 |
| Smith, Alexander K; Earle, Craig C; McCarthy, Ellen P (2009) Racial and ethnic differences in end-of-life care in fee-for-service Medicare beneficiaries with advanced cancer. J Am Geriatr Soc 57:153-8 |
| Earle, Craig C; Landrum, Mary Beth; Souza, Jeffrey M et al. (2008) Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol 26:3860-6 |
| Earle, Craig C; Ayanian, John Z (2006) Looking back from death: the value of retrospective studies of end-of-life care. J Clin Oncol 24:838-40 |
| Earle, Craig C; Neville, Bridget A; Landrum, Mary Beth et al. (2005) Evaluating claims-based indicators of the intensity of end-of-life cancer care. Int J Qual Health Care 17:505-9 |
| Earle, Craig C; Neville, Bridget A; Landrum, Mary Beth et al. (2004) Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 22:315-21 |
Showing the most recent 10 out of 12 publications
